期刊文献+

厄贝沙坦对肾小球硬化大鼠肾组织肝细胞生长因子的调节 被引量:2

Effect of Irbesartan on Renal Expression of Hepatocyte Growth Factor in Glomerular Sclerosis in Rats
下载PDF
导出
摘要 目的 :探讨厄贝沙坦对肾切除加重复阿霉素注射的方法复制的肾小球硬化模型大鼠肾组织肝细胞生长因子 (HGF)分泌的调节。方法 :将肾小球硬化大鼠分为厄贝沙坦治疗组和对照组 ,设假手术组为正常对照。检测厄贝沙坦治疗 8周后的肾功能和组织病理改变 ,用免疫组化方法检测肾小球和肾小管 间质中HGF的表达 ,并用ELISA法比较各组大鼠肾组织分泌的HGF。结果 :厄贝沙坦治疗组较对照组肾组织HGF的表达增加 ,肾组织分泌的HGF含量增加。结论 :厄贝沙坦可以上调肾组织HGF的分泌 ,加强HGF的肾保护作用 ,延缓肾小球硬化 ,减轻肾小管 间质纤维化。 Objective: To investigate the effect of irbesartan on renal expression of hepatocyte growth factor(HGF) in glomerular sclerosis in rats which were induced by unilateral nephrectomy followed by double intravenous injection of adriamycin. Methods: The rats were randomly divided into three groups:normal group,control group and irbesartan treatment group. Rats with sham operation served as normal control group. After 8 weeks'treatment,the renal function and histopathological changes were evaluated. Immunohistochemistry was used to examine the expression of HGF in renal tissue. And excretion of renal HGF was compared by ELISA. Results: The expression and excretion of renal HGF in irbesartan treatment group was significantly higher than that in control group. Conclusion: Irbesartan can up-regulate the renal HGF,strengthen its renotrophic function and retard the development of glomerular sclerosis and tubulointerstitial fibrosis.
出处 《武汉大学学报(医学版)》 CAS 2004年第2期137-140,共4页 Medical Journal of Wuhan University
关键词 肾小球硬化 肾小管-间质纤维化 肝细胞生长因子 厄贝沙坦 glomerular sclerosis tubulointerstitial fibrosis hepatocyte growth factor irbesartan
  • 相关文献

参考文献12

  • 1Eddy AA. Molecular insight into renal interstitial fibrosis.J Am Soc Nephrol,1996,7(11):2 495
  • 2Youhua Liu,Krupa Ra,Evelyn To,et al. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways. Kidney Int,2000,58 (5):2 028
  • 3Yoshikage Yo,Ryuichi M,Kei Ya,et al. Actions of hepatocyte growth factor as a local modulator in the Kidney: Potential role in pathogenesis of renal disease. Kidney Int,1998,53(1):50
  • 4Boros P, Miller CM. Hepatocyte growth factor: A multifunction cytokine. Lancet,1995,345:293
  • 5Igawa T. Hepatocyte growth factor is a potent mitogen for a cultured rabbit renal tubular epithelial cells. Biochem Biophys Res Comm,1991,174(5):831
  • 6Miller SB. Hepatocyte growth factor accelerates recovery from acute ischemic renal injury in rat .Am J physiol,1994,266:F129
  • 7Yoshika Yo,Ryuichi Mo,Shigefumi Na,et al. Potential role of hepatocyte growth factor in the maintenance of renal structure: Anti-apoptotic action of HGF on epithelial cells. Kidney Int,1998,54 (4):1 128
  • 8Kuion M,Toshikazu N. Renotropic role and potential therapeutics for renal disease. Kidney Int,2001,59(6):2 023
  • 9Shinya Mizuno,Tsutomu Kurosawa,Kunio Matsumoto,et al. Hepatocyte growth factor prevents renal fibrosis and dysfunction in a mouse model of chronic renal disease. J Clin Invest,1998,101(9):1 827
  • 10Shinya Mizuno,Kunio M,Toshikazu N. Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy. Kidney Int,2001,59(4):1 304

同被引文献22

  • 1姚兰,陈海平,张丽,唐淑珍.肝细胞生长因子对高糖条件下系膜细胞基质降解酶系统及转化生长因子β1的影响[J].首都医科大学学报,2008,29(3):321-326. 被引量:1
  • 2Youhua Liu, krupa Ra, Evelyn To, et al. Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradage pathways. Kidney Int, 2000,58 : 2028.
  • 3Lewis E. The role of angiotension Ⅱ receptor blockers in preventing the progressin renal disease in patients with type 2 diabetes. Am Hypertension, 2002,15 : 123-128.
  • 4Kagawa T,Takemura G, Kosai K, et al. Hepatocyte growth factor gene therapy slows down the p rogression of diabetic nephropathy in db/db mice. Nephron Physiol, 2005,102: 92-102.
  • 5Dai CS, Li YJ, Yang JW, et al. Hepatocyte growth factor preserves bata cell mass and mitigates hyperlycemia in streptozotocin induced diabetic mice. Biochem, 2003,278 : 80-87.
  • 6李玉梅 刘利民 贾文兰.鲫鱼赤小豆汤治疗高度水肿低蛋白血症.黑龙江医药,2000,13(1):45-45.
  • 7Ooi JD, Kitching AR, Holdsworth SR. Review: T helper 17 cells: their role in glomerulonephritis [ J ]. Nephrology (Carl- ton). 2010, 15(5): 513 -521.
  • 8Liu LL, Qin Y, Cai JF, et al. Th17/Treg imbalance in adult pa- tients with minimal change nephrotic syndrome [J]. Clin Immu- nol. 2011, 139(3) : 314 -320.
  • 9Matsumoto K, Kanmatsuse K. Increased urinary excretion of in- terleukin-17 in nephrotic patients [J]. Nephron. 2002, 91 (2) : 243 - 249.
  • 10Iwakura Y, Ishigame H, Saijo S, et al. Functional specialization of interleukin-17 family members [J]. Immunity. 2011,34(2) : 149 - 162.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部